Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 4:14 pm Purchase | 2025-04-03 | 13G | Protagonist Therapeutics, Inc. PTGX | Deep Track Capital, LP | 3,250,000 5.290% | 3,250,000 (New Position) | Filing History |
| 2025-03-26 4:09 pm Purchase | 2025-03-19 | 13G | Immunovant, Inc. IMVT | Deep Track Capital, LP | 9,500,000 5.590% | 8,500,000 (+850.00%) | Filing History |
| 2025-03-25 4:06 pm Purchase | 2025-03-18 | 13G | Geron Corporation GERN | Deep Track Capital, LP | 35,000,000 5.500% | 27,424,951 (+362.04%) | Filing History |
| 2025-03-24 4:08 pm Purchase | 2025-03-17 | 13G | Dianthus Therapeutics, Inc. DNTH | Deep Track Capital, LP | 2,357,702 7.340% | 2,357,702 (New Position) | Filing History |
| 2025-02-19 9:51 pm Unchanged | 2025-02-18 | 13D | Dynavax Technologies Corporation DVAX | Deep Track Capital, LP | 17,791,486 13.500% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2025-02-07 | 13G | Ikena Oncology, Inc. IKNA | Deep Track Capital, LP | 2,515,513 5.210% | 2,515,513 (New Position) | Filing History |
| 2025-02-14 4:31 pm Purchase | 2025-02-07 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 4,125,000 5.440% | 1,125,000 (+37.50%) | Filing History |
| 2025-02-14 08:48 am Sale | 2024-12-31 | 13G | OnKure Therapeutics, Inc. OKUR | Deep Track Capital, LP | 523,989 4.140% | -136,147 (-20.62%) | Filing History |
| 2025-02-14 08:48 am Sale | 2024-12-31 | 13G | Pyxis Oncology, Inc. PYXS | Deep Track Capital, LP | 0 0.000% | -4,184,100 (Position Closed) | Filing History |
| 2025-02-14 08:46 am Purchase | 2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | Deep Track Capital, LP | 4,557,575 8.940% | 2,307,575 (+102.56%) | Filing History |
| 2025-02-14 08:45 am Sale | 2024-12-31 | 13G | Editas Medicine, Inc. EDIT | Deep Track Capital, LP | 0 0.000% | -5,473,086 (Position Closed) | Filing History |
| 2025-02-14 08:44 am Sale | 2024-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Deep Track Capital, LP | 3,460,756 4.650% | -602,920 (-14.84%) | Filing History |
| 2025-02-14 08:43 am Sale | 2024-12-31 | 13G | Nektar Therapeutics NKTR | Deep Track Capital, LP | 1,975,998 1.070% | -13,946,657 (-87.59%) | Filing History |
| 2025-02-14 08:42 am Purchase | 2024-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 3,000,000 4.240% | 2,170 (+0.07%) | Filing History |
| 2025-02-14 08:41 am Sale | 2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Deep Track Capital, LP | 0 0.000% | -699,281 (Position Closed) | Filing History |
| 2025-02-14 08:41 am Sale | 2024-12-31 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital, LP | 3,330,236 6.710% | -160,270 (-4.59%) | Filing History |
| 2025-02-14 08:40 am Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 609,900 1.320% | -3,486,552 (-85.11%) | Filing History |
| 2025-02-10 4:04 pm Purchase | 2025-02-03 | 13G | Tectonic Therapeutic, Inc. TECX | Deep Track Capital, LP | 1,401,938 7.600% | 1,401,938 (New Position) | Filing History |
| 2025-02-07 4:30 pm Purchase | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Deep Track Capital, LP | 3,023,484 6.910% | 3,023,484 (New Position) | Filing History |
| 2025-01-17 4:02 pm Purchase | 2025-01-10 | 13G | COMPASS Pathways plc CMPS | Deep Track Capital, LP | 9,274,589 9.990% | 9,274,589 (New Position) | Filing History |